m.adeyemi

TL2 · Wrocław

Contributes reviews on supplier material. Based in Wrocław.

Joined 19 September 2025 · last posted 1d

66 posts, newest first. Showing up to 150.

What I would want from a home test that does not exist yet Replied, post #50 · Analytics › Home & field testing · 27 Jul 2026 · 4 likes Narrowing post #49, because the general version has more than one answer. A test that gives a yes or no on the presence of peptide bonds is answering a genuinely useful…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #109 · Evidence › Journal club · 24 Jul 2026 · 0 likes Whatever the answer on SUSTAIN 6 turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
Ultrasound and skinfolds: operator dependence in practice Replied, post #69 · Outcomes › Body composition · 21 Jul 2026 · 0 likes Same experience here, different supplier, so it is at least not unique to one of them.
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #96 · Start Here › Welcome · 19 Jul 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Revisiting: Protein density versus volume when you cannot eat much Replied, post #63 · Nutrition & Training › Protein & intake · 14 Jul 2026 · 5 likes No notes. Posting so the count is not one.
Alcohol: what is documented and what is folklore Replied, post #108 · Practice › Interactions · 12 Jul 2026 · 8 likes Post #105 is right about the mechanism and I think understates the practical bit. Alcohol: I have looked for the primary source twice and failed twice. Either it does…
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #47 · Pharmacology › Pharmacokinetics · 10 Jul 2026 · 4 likes Answering the question post #43 raises rather than the one it answers. A missed weekly dose perturbs a slowly moving average rather than creating a trough. That is the…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #68 · Compounds › Secretagogues & GH axis · 9 Jul 2026 · 0 likes Answering the question post #66 raises rather than the one it answers. The most useful reply I ever got about secretagogues and glucose tolerance was a request to state…
Follow-up: Prior authorisation: what the criteria usually require Replied, post #43 · Access › Insurance & coverage · 28 Jun 2026 · 23 likes Coming back to post #41, because the follow-up matters more than the original answer. Summarising the Prior authorisation thread so far, since it is long and the answer…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #54 · Analytics › Home & field testing · 21 Jun 2026 · 0 likes Adding thanks rather than a view. I do not have a view worth the space.
What would change my mind about repair peptides: a specific answer Replied, post #5 · Compounds › Repair & healing peptides · 1 Jun 2026 · 0 likes Confirming post #3 from a second method, which matters more than confirming it from a second person. The lyophilised cake is worth looking at before adding diluent. A…
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #21 · Practice › Dosing & titration · 17 May 2026 · 1 like When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
Request: show the solution author in the topic list — what changed since Replied, post #67 · Meta › Feature requests · 3 May 2026 · 9 likes I had written a reply contradicting post #63 and deleted it. Here is what survived. Feature request I expect to be refused, stated anyway: a private notes field on a…
Reconstitution volumes that produce round numbers, tabulated Replied, post #96 · Practice › Reconstitution · 21 Apr 2026 · 5 likes Whatever the answer on reconstitution volumes turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the…
Type 2 diabetes and the largest part of the evidence base Replied, post #76 · Clinical › Comorbidities · 20 Apr 2026 · 11 likes Where I have landed on type 2 diabetes, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has…
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #18 · Compounds › Semaglutide · 20 Apr 2026 · 0 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #64 · Analytics › Method validation · 13 Apr 2026 · 22 likes Coming back to post #62, because the follow-up matters more than the original answer. Robustness: the method gives consistent results when minor parameters vary. Tested…
A plateau that disappeared when I changed how I measured — the long version Replied, post #23 · Outcomes › Progress reports · 4 Apr 2026 · 18 likes Post #19 put the caveat in the right place and I want to underline it. Worth separating plateau as a question about the compound from plateau as a question about the…
Coming back to: Training through a dose escalation week Replied, post #68 · Nutrition & Training › Resistance training · 2 Apr 2026 · 0 likes Careful with the language on Training through a dose escalation. "Not detected" and "not present" are different findings and the first is a statement about the method.
Second pass at: The storage lookup and where its data comes from Replied, post #2 · Data & Tools › Calculators · 1 Apr 2026 · 0 likes Storage lookup came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #55 · Compounds › Cagrilintide & amylin analogues · 10 Mar 2026 · 14 likes Small correction to my own earlier position on nausea profile of amylin analogues. I had the units the wrong way round, which changes the conclusion by an order of…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #38 · Clinical › Special populations · 22 Jan 2026 · 21 likes The reason Pregnancy and pregnancy planning keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #54 · Practice › Storage & stability · 21 Jan 2026 · 29 likes Where I would push back on the Storing lyophilised material long term consensus is the confidence, not the direction. The direction looks right. The confidence is…
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #38 · Research Methods › N-of-1 designs · 20 Jan 2026 · 23 likes Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures (weight, strength on a specific exercise) are less…
Pooling trials with different estimands — what changed since Replied, post #62 · Evidence › Meta-analyses · 7 Dec 2025 · 3 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
An inter-laboratory comparison on one lot, tabulated — what changed since Replied, post #17 · Analytics › Method validation · 19 Nov 2025 · 9 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
Cross-border purchase rules within the EU Replied, post #37 · Regional › European Union · 11 Nov 2025 · 0 likes Anyone quoting an eligibility threshold should cite the national document, because thresholds differ between states and have changed within them.
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #33 · Sourcing › Vendor reports · 9 Nov 2025 · 0 likes Narrowing post #30, because the general version has more than one answer. The cost of a submission is worth stating. It is the main reason people do not do this and…
Sleep tracking data and its considerable limitations Replied, post #44 · Wellbeing › Sleep · 20 Oct 2025 · 4 likes Building on post #41 rather than restating it. Appetite suppression and nighttime eating: if nighttime eating was a pattern, appetite suppression changes that pattern.…
Payment mechanics and the recovery options that do not exist Replied, post #13 · Sourcing › Payments · 19 Oct 2025 · 0 likes Right, and stated more narrowly than I would have dared to state it.
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #47 · Compounds › Tirzepatide · 17 Oct 2025 · 11 likes My understanding of dual agonism is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
Request: a diff view for wiki revisions — the long version Replied, post #56 · Meta › Feature requests · 15 Oct 2025 · 0 likes The arithmetic in post #53 is right; the assumption feeding it is the part to check. One more thing on diff view for wiki revisions that took me far too long to see:…
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #72 · Evidence › Preprints · 1 Oct 2025 · 0 likes Answering the question post #68 raises rather than the one it answers. If you are new and reading this thread for the answer to Citing a preprint: the answer is…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #107 · Compounds › Retatrutide · 7 Sep 2025 · 8 likes Post #105 and I disagree about the size of the effect, not about the direction. Triple agonism has been discussed here with more heat than it deserves, mostly because…
A comparison of home results against a laboratory result on the same vial Replied, post #26 · Analytics › Home & field testing · 18 Aug 2025 · 0 likes Coming back to post #24, because the follow-up matters more than the original answer. The honest cost comparison is a home kit against a single independent submission.…
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #20 · Evidence › Preprints · 17 Aug 2025 · 22 likes Building anything durable on a preprint means committing to rebuild it. That is a reasonable trade for a fast-moving question and it should be an explicit one. If it…
Hepatic impairment and the absence of data Replied, post #11 · Clinical › Special populations · 12 Aug 2025 · 14 likes Worth separating hepatic impairment as a question about the compound from hepatic impairment as a question about the documentation. They get answered by different…
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #28 · Evidence › Journal club · 12 Aug 2025 · 8 likes I keep a log for indirect comparison specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and…
Managing an unplanned gap in supply — what changed since Replied, post #35 · Access › Shortages · 10 Aug 2025 · 1 like Regional differences during a shortage are large, and a supply position in one country says nothing about another. I have seen it go both ways, which is why I hedge.
A ten-fold dose error caught before injection — one year on Replied, post #132 · Devices › Syringes & needles · 4 Aug 2025 · 28 likes Everything in post #130 holds. The case it does not cover is the one I have. Buying a box of the wrong barrel size is the most common regret described in this…
Hepatic impairment and the absence of data Started this topic · Clinical › Special populations · 22 Jul 2025 · 17 likes Hepatic impairment and the absence of data — setting out what I have, and where I think it stops being reliable. I was wrong about hepatic impairment in a thread last…
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #23 · Analytics › COA interpretation · 16 Jul 2025 · 10 likes Post #22 is right about the mechanism and I think understates the practical bit. The distinction between release testing and characterisation is one industrial…
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #4 · Compounds › Cagrilintide & amylin analogues · 4 Jul 2025 · 0 likes Anyone submitting this for independent testing should say in the submission that it is an amylin analogue rather than an incretin. Method selection differs and a…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #152 · Practice › Reconstitution · 2 Jul 2025 · 0 likes Sensible. I would want the same detail before I acted on it either.
Interim analyses and stopping rules — does this still hold? Replied, post #13 · Evidence › Trials · 27 Jun 2025 · 3 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
A report I filed that turned out to be wrong, and the correction Replied, post #125 · Sourcing › Vendor reports · 27 Jun 2025 · 0 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere.
Telehealth prescribing models in the US Replied, post #93 · Regional › North America · 3 May 2025 · 0 likes That is a fair summary of where the discussion has got to.
Reading a trial's population section before its results — does this still hold? Replied, post #43 · Evidence › Trials · 26 Apr 2025 · 20 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
Coming back to: Sample size calculations, read backwards from the published number Replied, post #14 · Evidence › Trials · 18 Apr 2025 · 0 likes Reading back through the Sample size calculations threads from last year, the same three questions come up every time and only one of them has ever been answered…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #9 · marked as the solution · Evidence › Trials · 10 Apr 2025 · 10 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
A supplier who responds to a discrepancy with silence Replied, post #3 · Sourcing › Red flags · 8 Apr 2025 · 1 like Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
Retatrutide dose escalation in the published trials Replied, post #60 · Compounds › Retatrutide · 28 Mar 2025 · 32 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #4 · Devices › Cold chain · 25 Feb 2025 · 10 likes My understanding of Airline travel is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
Research-use-only status: what it means legally and practically — a second dataset Replied, post #85 · Compounds › Other compounds · 9 Feb 2025 · 2 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Why the Start Here categories exist, and what they are not for — one year on Replied, post #14 · Start Here › Welcome · 30 Jan 2025 · 6 likes Reading the guidelines before you post is genuinely worth the twenty minutes. Not because you will break one, but because the rules explain why the place reads the way…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #16 · Compounds › Semaglutide · 3 Jan 2025 · 7 likes Gallbladder events appear in the labelling for this class and are more common with larger, faster weight reduction. The mechanism is not specific to the drug — rapid…
Persistent vomiting and the threshold for seeking help — one year on Replied, post #4 · Safety › Adverse events · 18 Dec 2024 · 0 likes Confirming the opening post from a second method, which matters more than confirming it from a second person. My experience of Persistent vomiting contradicts the reply…
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #25 · Clinical › Special populations · 21 Nov 2024 · 10 likes Distinguishing three things in the Type 1 diabetes discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation…
Second pass at: Buffers, pH and why a formulation is a formulation Replied, post #8 · Pharmacology › Formulation chemistry · 21 Oct 2024 · 0 likes Second-hand on Buffers, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #58 · Clinical › Comorbidities · 18 Oct 2024 · 29 likes Building on post #57 rather than restating it. On Hypertension improvement, I would rather understate and be corrected upward than overstate and be quoted. That is a…
Progressive overload when the scale is falling — one year on Replied, post #124 · Nutrition & Training › Resistance training · 5 Oct 2024 · 0 likes Post #121 describes the usual case. This is about the unusual one. What I can speak to on Progressive overload is narrow, so I will keep it narrow rather than…
Reporting a discrepancy without making an allegation Replied, post #77 · Sourcing › Vendor reports · 16 Sep 2024 · 11 likes Everything in post #73 holds. The case it does not cover is the one I have. Do not adjust a reported figure. Post what the laboratory said and put your interpretation…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #50 · Clinical › Prescriber conversations · 3 Sep 2024 · 27 likes Write the questions down in advance and put the most important one first. Appointments end and the order is what decides which questions get answered. I looked this up…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #16 · Nutrition & Training › Hydration & electrolytes · 28 Jul 2024 · 0 likes Noted, and thank you for writing it out rather than summarising it.
Journal club: FLOW and the renal composite, component by component Replied, post #51 · Evidence › Journal club · 14 Jul 2024 · 0 likes Everything in post #47 holds. The case it does not cover is the one I have. Sessions on negative or null results are consistently the most instructive and the hardest…
Identical chromatograms across two different lots Started this topic · Sourcing › Red flags · 20 Jun 2024 · 43 likes Identical chromatograms across two different lots Writing it up because I had to work it out twice and would rather nobody else did. Collecting what is known about…